>
Bioiasis AD logo

BIOA - Bioiasis AD Share Price

BGN16.08 -0.3  -1.8%

Last Trade - 07/01/15

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £n/a
Position in Universe th / 646
Bullish
Bearish
Unlock BIOA Revenue
Momentum
Relative Strength (%)
1m -4.43%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.12 0.13 0.18 0.10 0.001 0.000 -100.0%
+207.8 +33.3
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, BioiasisAD revenues decreased from BGN1K to BGN0K. Net loss totaledBGN50K vs. income of BGN535K. Revenues reflect a decreasein demand for the Company's products and services due tounfavorable market conditions. Net loss reflects OtherFinancial Income decrease of 87% to BGN54K (income),Employee Related Expenses increase of 32% to BGN25K(expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

BIOA Revenue Unlock BIOA Revenue

Net Income

BIOA Net Income Unlock BIOA Revenue

Normalised EPS

BIOA Normalised EPS Unlock BIOA Revenue

PE Ratio Range

BIOA PE Ratio Range Unlock BIOA Revenue

Dividend Yield Range

BIOA Dividend Yield Range Unlock BIOA Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
BIOA EPS Forecasts Unlock BIOA Revenue
Profile Summary

Bioiasis AD is a Bulgaria-based company that specializes in the wholesale of biomaterial products surgical supplies such as medicines, medical materials and instruments, sanitary and hygienic products, disinfectants, medical cosmetics and appliances, as well as medical equipment and consumables. The Company distributes cardiology products like Paclitaxel Eluting Balloon and Paclitaxel Eluting Stent; orthopedics products like Lineage Acetabular Cups, Advance Medical Pivot Knee and Olympia Total Shoulder System; neurosurgery products like pressure valve, mano-pressure valve, cervical disc, cervical cage and anterior cervical plate; and hemostasis products like haemostatic gauze, haemostatic powder and resorbable collagen hemostat. The Company distributes its products nationally and internationally, in Bulgaria, Greece, Cyprus, Romania, Serbia, the Russian Federation and the United States.

Directors
Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated April 18, 2005
Public Since May 8, 2008
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange Bulgarian Stock Exchange
Shares in Issue 1,171,215
Free Float (0.0%)
Eligible for
ISAs
SIPPs
BIOA Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for BIOA
Upcoming Events for BIOA
Frequently Asked Questions for Bioiasis AD
What is the Bioiasis AD share price?

As of 07/01/15, shares in Bioiasis AD are trading at BGN16.08, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the Bioiasis AD share price performed this year?

Shares in Bioiasis AD are currently trading at BGN16.08 and the price has moved by -18.38% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Bioiasis AD price has moved by -36.75% over the past year.

What are the analyst and broker recommendations for Bioiasis AD?

There are no analysts currently covering Bioiasis AD.

When will Bioiasis AD next release its financial results?

Bioiasis AD is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Bioiasis AD dividend yield?

Bioiasis AD does not currently pay a dividend.

Does Bioiasis AD pay a dividend?

Bioiasis AD does not currently pay a dividend.

When does Bioiasis AD next pay dividends?

Bioiasis AD does not currently pay a dividend.

How do I buy Bioiasis AD shares?

To buy shares in Bioiasis AD you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Bioiasis AD?

Shares in Bioiasis AD are currently trading at BGN16.08, giving the company a market capitalisation of £n/a.

Where are Bioiasis AD shares listed? Where are Bioiasis AD shares listed?

Here are the trading details for Bioiasis AD:

Country of listing: Bulgaria
Exchange: BLG
Ticker Symbol: BIOA
What kind of share is Bioiasis AD?

We were not able to load our ranking data for Bioiasis AD

Is there a Bioiasis AD share price forecast 2021?

We were not able to load any forecast data for Bioiasis AD.

How can I tell whether the Bioiasis AD share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Bioiasis AD. Over the past six months, the relative strength of its shares against the market has been -22.73%. At the current price of BGN16.08, shares in Bioiasis AD are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Bioiasis AD PE Ratio?

We were not able to find PE ratio data for Bioiasis AD.

Who are the key directors of Bioiasis AD?

Bioiasis AD's management team is headed by:

Paraskevi Kisas - DRC
Dimitrios Dumbalis - DRC
Gergana Yordanova - CEO
Who are the major shareholders of Bioiasis AD?

Here are the top five shareholders of Bioiasis AD based on the size of their shareholding:

Similar to BIOA
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.